Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1990;16:662-668

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Childs, T. J.
Right arrow Articles by Mak, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Childs, T. J.
Right arrow Articles by Mak, A. S.

Hypertension, Vol 16, 662-668, Copyright © 1990 by American Heart Association


ARTICLES

Regression of cardiac hypertrophy in spontaneously hypertensive rats by enalapril and the expression of contractile proteins

TJ Childs, MA Adams and AS Mak
Department of Biochemistry, Queen's University, Kingston, Ontario, Canada.

Several experimental models involving the development of cardiac hypertrophy in adult rats are characterized by the reexpression of the fetal isoform of myosin heavy chain (V3). To determine whether a similar adult-to-fetal shift in the expression of the thin-filament proteins occurs during cardiac hypertrophy, we have examined the expression of the isoforms of myosin, tropomyosin, and troponin T in the left ventricle of young spontaneously hypertensive rats (SHR) with and without treatment using enalapril, an angiotensin converting enzyme inhibitor. Phosphorylation of tropomyosin, which is predominant in the fetal state, was also analyzed. Twelve-week-old SHR were treated with enalapril for 2, 5, 8, and 9 weeks followed by withdrawal of treatment for 9 weeks. Control SHR, without drug treatment, were weight- and age- matched. After 9 weeks of enalapril treatment, mean arterial blood pressure was reduced (from 166 +/- 11 to 89 +/- 5 mm Hg), and left ventricular weight/body weight ratio was regressed (from 2.53 +/- 0.14 to 1.96 +/- 0.05 g/kg) to normotensive levels. During the 9-week treatment period, the percent V3 decreased in SHR substantially from 35 +/- 3% to 13 +/- 1%. There was a significant correlation between the left ventricular hypertrophy and the percent V3 myosin expression in the SHR during regression (r = 0.697, p less than 0.001). However, only the adult isoforms of tropomyosin and troponin T were detected in the SHR with or without enalapril treatment, and the level of tropomyosin phosphorylation remained constant irrespective of the degree of left ventricular hypertrophy.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. C. Leary, D. Michaud, C. N. Lyons, T. M. Hale, T. L. Bushfield, M. A. Adams, and C. D. Moyes
Bioenergetic remodeling of heart during treatment of spontaneously hypertensive rats with enalapril
Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H540 - H548.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. Zicha and J. Kunes
Ontogenetic Aspects of Hypertension Development: Analysis in the Rat
Physiol Rev, October 1, 1999; 79(4): 1227 - 1282.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. K. McConnell, C. S. Moravec, and M. Bond
Troponin I phosphorylation and myofilament calcium sensitivity during decompensated cardiac hypertrophy
Am J Physiol Heart Circ Physiol, February 1, 1998; 274(2): H385 - H396.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Yamazaki, I. Komuro, Y. Zou, S. Kudoh, I. Shiojima, T. Mizuno, Y. Hiroi, R. Nagai, and Y. Yazaki
Efficient Inhibition of the Development of Cardiac Remodeling by a Long-Acting Calcium Antagonist Amlodipine
Hypertension, January 1, 1998; 31(1): 32 - 38.
[Abstract] [Full Text]


Home page
HypertensionHome page
N. Makino, M. Sugano, S. Otsuka, and T. Hata
Molecular Mechanism of Angiotensin II Type I and Type II Receptors in Cardiac Hypertrophy of Spontaneously Hypertensive Rats
Hypertension, October 1, 1997; 30(4): 796 - 802.
[Abstract] [Full Text]


Home page
HypertensionHome page
S. Kim, K. Ohta, A. Hamaguchi, T. Yukimura, K. Miura, and H. Iwao
Angiotensin II Induces Cardiac Phenotypic Modulation and Remodeling In Vivo in Rats
Hypertension, June 1, 1995; 25(6): 1252 - 1259.
[Abstract] [Full Text]


Home page
CirculationHome page
L. Nascimben, J. Friedrich, R. Liao, P. Pauletto, A. C. Pessina, and J. S. Ingwall
Enalapril Treatment Increases Cardiac Performance and Energy Reserve Via the Creatine Kinase Reaction in Myocardium of Syrian Myopathic Hamsters With Advanced Heart Failure
Circulation, March 15, 1995; 91(6): 1824 - 1833.
[Abstract] [Full Text]